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Armin Braun, a plant geneticist in the 
1950–60’s at the Rockefeller, was the 
first to provide experimental evidence for 
tumor reversion in plants.1 Through set-
ting up his experiments in plants, Braun 
made of tumor reversion a philogeneti-
cally conserved system. With today’s 
understanding of the tumor cell plasticity, 
pluripotentiality and stemness, Braun’s 
words1 spelt 50 years ago sound almost 
magic: “results of this study indicate that 
the capacity of teratoma tissue of single 
cell origin to organize is a reflection of the 
inherent potentialities of pluripotent tumor 
cells... clones of teratoma tissue of single-cell 
origin developed organized structures … a 
controlled recovery of crown-gall tumor cells 
could be accomplished”. However, Braun’s 
findings have never been explained at the 
molecular level, and even their malignant 
phenotype remains to be explored. By 
studying tumor reversion in human can-
cer cells, we found that Translationally 
Controlled Tumor Protein (TCTP) is a 
key gene that needs to be switched off in 
order to quit the malignant process and 
revert.2,3 Could TCTP be the molecular 
link to Armin Braun’s findings?
Translationally Controlled Tumor 
Protein (TCTP) knockout in mice 
causes embryonic lethality, showing 
that this gene is essential for develop-
ment.4 Most interestingly, Brioudes et al.5 
recently reported that TCTP knockout 
in plants also resulted in a lethal pheno-
type. TCTP-lacking adult plants could 
be rescued by “feeding” the embryos, 
and the same phenotype, i.e., small size 
plants, were observed using the RNAi 
approach. Importantly the KO phenotype 
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of Arabidopsis thaliana was rescued by 
Drosophila TCTP and vice versa. Thus 
TCTP seems to integrate signals control-
ling cell cycle progression, proliferation 
and cell sizing. Brioudes et al. provide con-
siderable insight into these issues through 
analysis of the first TCTP-lacking adult 
multicellular organisms. Moreover, this 
study may provide a missing link with 
early studies by Armin Braun.
Knocking down Arabidopsis TCTP 
slows down the cell cycle; G
1
-phase, when 
cells grow, is significantly prolonged (4 
hrs) and M-phase entry is reduced. Does 
TCTP integrate cell sizing into the cell 
cycle machinery? If yes, it acts both on 
the S- and M-phase via downregulation 
of specific markers: PCNA for S- and 
cyclin B for M-phase. In animal cells 
TCTP also associates with F-actin fibers 
at the cell periphery, regulating cell shape 
both in interphase and in mitosis and cell 
motility.6 This interaction may likely be 
assured through the TCTP cofilin-like 
domain.7 On the other hand, the localiza-
tion of TCTP to the mitotic spindle does 
not seem to implicate a direct associa-
tion with microtubules.6 Hence, TCTP-
cytoskeleton interaction becomes elusive 
and clearly requires more detailed analysis.
Genetic experiments in Drosophila 
linked TCTP to the TOR pathway.8 Our 
data futher indicate that TCTP associ-
ates with the protein synthesis-initiation 
and -elongation machinery.3 We found 
that besides interacting with eEF1A, it 
may also interact with the eIF3 complex 
(unpublished results), which is under 
the control of mTOR, as shown by John 
Blenis’ work,9 providing hereby a potential 
alternative molecular explanation for the 
genetic TCTP-TOR connection. TCTP 
also regulates the expression of oct4 and 
nanog, early embryonic genes, in nuclear 
reprogramming, as shown by John 
Gurdon’s group.10 Thus, TCTP seems 
more than ever to act on multiple path-
ways, making simultaneously numerous 
imprints on cell physiology. This may pre-
dispose TCTP to be an omnipresent fac-
tor able not only to drive, but also to assist 
efficiently major cell functions.
With the clear understanding that 
plant tumors are very different from 
human ones, nevertheless, to explore to 
what extend some pathways are conserved, 
an “easy experiment” would be to test 
whether silencing of TCTP could revert 
tumor formation in plants. Conversely, 
could forced expression of plant TCTP 
transform our revertants back into aggres-
sive tumor cells? We would have at least 
some molecular explanations for Braun’s 
results.
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